Fungal endophthalmitis

Current Fungal Infection Reports

Volumn 3, Issue 1, 2009, Pages 55-61

  Wu, Lihteh ^a   Tapia Herrera, Guillermo ^b  

^a Instituto de Cirugia Ocular   (Costa Rica)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CHOROID; CLINICAL FEATURE; COCCIDIOIDES IMMITIS; DISEASE SEVERITY; EARLY DIAGNOSIS; ENDOPHTHALMITIS; EYE SURGERY; EYE TOXICITY; FEVER; FUNGAL VIRULENCE; FUNGUS ISOLATION; HUMAN; HYPOTENSION; LOADING DRUG DOSE; MORTALITY; NEPHROTOXICITY; NONHUMAN; PIGMENT EPITHELIUM; PROGNOSIS; RASH; RETINA BLOOD VESSEL OCCLUSION; RETINA HEMORRHAGE; REVIEW; RIGOR; SINGLE DRUG DOSE; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; VISUAL DISORDER; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS BODY;

EID: 77953457588     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-009-0008-8     Document Type: Review

References (48)

1. Lalwani GA, Flynn HW Jr, Scott IU, et al.Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology 2008, 115:473-476.
2. Anand AR, Therese KL, Madhavan HN: Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol 2000, 48:123-128.
3. Narendran N, Balasubramaniam B, Johnson E, et al.Five-year retrospective review of guideline-based management of fungal endophthalmitis. Acta Ophthalmol 2008, 86:525-532.
4. Romer P: Eine intraoculare Schimmelpilz-infection. Klin Monatsbl Augenheilkd 1902, 40:331-333.
5. Rychener RO: Intra-ocular mycosis. Trans Am Acad Ophthalmol Soc 1933, 31:477-496.
6. Wykoff CC, Flynn HW Jr, Miller D, et al.Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology 2008, 115:1501-1507.
7. Pflugfelder SC, Flynn HW JR, Zwickey TA, et al.Exogenous fungal endophthalmitis. Ophthalmology 1988, 95:19-30.
8. Chakrabarti A, Shivaprakash MR, Singh R, et al.Fungal endophthalmitis: fourteen years' experience from a center in India. Retina 2008, 28:1400-1407.
9. Essman TF, Flynn HW Jr, Smiddy WE, et al.Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1997, 28:185-194.
10. Klotz SA, Penn CC, Negvesky GJ, Butrus SI: Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000, 13:662-685.
11. Schiedler V, Scott IU, Flynn HW Jr, et al.Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 2004, 137:725-731.
12. Shah CP, McKey J, Spirn MJ, Maguire J: Ocular candidiasis: a review. Br J Ophthalmol 2008, 92:466-468.
13. Rao NA, Hidayat A: A comparative clinicopathologic study of endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared to aspergillosis. Trans Am Ophthalmol Soc 2000, 98:183-193.
14. Lundquist O, Osterlin S: Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefes Arch Clin Exp Ophthalmol 1994, 232:71-74.
15. Brooks RG: Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 1989, 149:2226-2228.
16. Feman SS, Nichols JC, Chung SM, Theobald TA: Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 2002, 100:67-70.
17. Henderson DK, Edwards JE Jr, Montgomerie JZ: Hematogenous candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis 1981, 143:655-661.
18. Martinez-Vazquez C, Fernandez-Ulloa J, Bordon J, et al.Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis 1998, 27:1130-1133.
19. Ness T, Pelz K, Hansen LL: Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand 2007, 85:852-856.
20. Weishaar PD, Flynn HW Jr, Murray TG, et al.Endogenous Aspergillus endophthalmitis. Clinical features and treatment outcomes. Ophthalmology 1998, 105:57-65.
21. Crump JR, Elner SG, Elner VM, Kauffman CA: Cryptococcal endophthalmitis: case report and review. Clin Infect Dis 1992, 14:1069-1073.
22. Custis PH, Haller JA, de Juan E Jr: An unusual case of cryptococcal endophthalmitis. Retina 1995, 15:300-304.
23. Sheu SJ, Chen YC, Kuo NW, et al.Endogenous cryptococcal endophthalmitis. Ophthalmology 1998, 105:377-381.
24. Cutler JE, Binder PS, Paul TO, Beamis JF: Metastatic coccidioidal endophthalmitis. Arch Ophthalmol 1978, 96:689-691.
25. Blumenkranz MS, Stevens DA: Endogenous coccidioidal endophthalmitis. Ophthalmology 1980, 87:974-984.
26. Zakka KA, Foos RY, Brown WJ: Intraocular coccidioidomycosis. Surv Ophthalmol 1978, 22:313-321.
27. Blumenkranz MS, Stevens DA: Therapy of endogenous fungal endophthalmitis: miconazole or amphotericin B for coccidioidal and candidal infection. Arch Ophthalmol 1980, 98:1216-1220.
28. Jaeger EE, Carroll NM, Choudhury S, et al.Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR. J Clin Microbiol 2000, 38:2902-2908.
29. Okhravi N, Adamson P, Lightman S: Use of PCR in endophthalmitis. Ocul Immunol Inflamm 2000, 8:189-200.
30. Anand A, Madhavan H, Neelam V, Lily T: Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis. Ophthalmology 2001, 108:326-330. (Pubitemid 32115964)
31. Khan FA, Slain D, Khakoo RA: Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy 2007, 27:1711-1721.
32. O'Day DM, Head WS, Robinson RD, et al.Intraocular penetration of systemically administered antifungal agents. Curr Eye Res 1985, 4:131-134.
33. Zhang YQ, Wang WJ: Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina 2005, 25:746-750.
34. Souri EN, Green WR: Intravitreal amphotericin B toxicity. Am J Ophthalmol 1974, 78:77-81.
35. Axelrod AJ, Peyman GA, Apple DJ: Toxicity of intravitreal injection of amphotericin B. Am J Ophthalmol 1973, 76:578-583.
36. Smiddy WE: Treatment outcomes of endogenous fungal endophthalmitis. Curr Opin Ophthalmol 1998, 9:66-70.
37. O'Day DM, Foulds G, Williams TE, et al.Ocular uptake of fluconazole following oral administration. Arch Ophthalmol 1990, 108:1006-1008.
38. Ohnishi Y, Tawara A, Murata T, et al.Postmortem findings two weeks after oral treatment for metastatic Candida endophthalmitis with fluconazole. Ophthalmologica 1999, 213:341-344.
39. Hariprasad SM, Mieler WF, Lin TK, et al.Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 2008, 92:871-878.
40. Gao H, Pennesi ME, Shah K, et al.Intravitreal voriconazole: an electroretinographic and histopathologic study. Arch Ophthalmol 2004, 122:1687-1692. [Published erratum appears in Arch Ophthalmol 2005, 123:130.]
41. Sponsel WE, Graybill JR, Nevarez HL, Dang D: Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br J Ophthalmol 2002, 86:829-830.
42. Tu EY, McCartney DL, Beatty RF, et al.Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592). Am J Ophthalmol 2007, 143:222-227.
43. Mora-Duarte J, Betts R, Rotstein C, et al.Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002, 347:2020-2029.
44. Gauthier GM, Nork TM, Prince R, Andes D: Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin Infect Dis 2005, 41:e27-28
45. Chignell AH: Endogenous candida endophthalmitis. J R Soc Med 1992, 85:721-724.
46. Luttrull JK, Wan WL, Kubak BM, et al.Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol 1995, 119:477-481.
47. Akler ME, Vellend H, McNeely DM, et al.Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis 1995, 20:657-664.
48. Coats ML, Peyman GA: Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis. Retina 1992, 12:46-51.